Drugs / VI
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01636713 | Jul 2012 → Oct 2013 | chronic obstructive pulmonary disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01636713 ↗ |
| Route | Inhaled | “Inhalation via Novel Dry Powder Inhaler Once a day” NCT01636713 ↗ |